Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Clinical trial NCT04508140 · TERMINATED
Trial details
- NCT number
- NCT04508140
- Sponsor
- Highlight Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2022-12-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.